A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996.
作者信息
Gallo J M, Hafeli U
出版信息
Cancer Res. 1997 Jul 15;57(14):3063-5.
PMID:9230223
Abstract
摘要
Zotero 插件